Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2537

1.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society.

Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Review.

PMID:
26642102
2.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES).

Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.

PMID:
26509855
3.

Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.

Yildiz BO, Yarali H, Oguz H, Bayraktar M.

J Clin Endocrinol Metab. 2003 May;88(5):2031-6.

PMID:
12727950
4.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
5.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M.

Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.

PMID:
28437620
6.

Metabolic Syndrome: Polycystic Ovary Syndrome.

Mortada R, Williams T.

FP Essent. 2015 Aug;435:30-42. Review.

PMID:
26280343
7.

Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.

Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.

JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.

PMID:
26720591
8.

Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.

Stovall DW, Bailey AP, Pastore LM.

J Womens Health (Larchmt). 2011 Jan;20(1):37-43. doi: 10.1089/jwh.2010.2053. Epub 2010 Dec 31.

9.

The treatment of polycystic ovary syndrome.

Ajossa S, Guerriero S, Paoletti AM, OrrĂ¹ M, Melis GB.

Minerva Ginecol. 2004 Feb;56(1):15-26.

PMID:
14973407
10.

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.

Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.

Hum Reprod. 2013 Mar;28(3):785-93. doi: 10.1093/humrep/des456. Epub 2013 Jan 12.

PMID:
23315058
11.

Polycystic ovary syndrome: a review for primary providers.

Buccola JM, Reynolds EE.

Prim Care. 2003 Dec;30(4):697-710. Review.

PMID:
15024892
12.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines.

Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL. Epub 2016 May 24.

PMID:
27219496
13.

Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.

Anaforoglu I, Algun E, Incecayir O, Ersoy K.

Metab Syndr Relat Disord. 2011 Oct;9(5):375-80. doi: 10.1089/met.2011.0019. Epub 2011 Jun 9.

PMID:
21657888
14.

Polycystic ovary syndrome in the Indian Subcontinent.

Allahbadia GN, Merchant R.

Semin Reprod Med. 2008 Jan;26(1):22-34. doi: 10.1055/s-2007-992921. Review.

PMID:
18181079
15.

Ovarian surgery for symptom relief in women with polycystic ovary syndrome.

Lepine S, Jo J, Metwally M, Cheong YC.

Cochrane Database Syst Rev. 2017 Nov 10;11:CD009526. doi: 10.1002/14651858.CD009526.pub2. Review.

16.

Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group.

J Clin Endocrinol Metab. 2005 Jan;90(1):66-71. Epub 2004 Oct 26.

PMID:
15507516
17.

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, Kumarapeli V, Palipane E, Kuruppu N, Yapa C, Seneviratne Rde A, Balen AH.

Hum Reprod. 2011 Jan;26(1):202-13. doi: 10.1093/humrep/deq310. Epub 2010 Nov 23.

PMID:
21098627
18.

Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Ezeh U, Pall M, Mathur R, Azziz R.

Hum Reprod. 2014 Jul;29(7):1508-17. Epub 2014 May 9.

19.

Polycystic ovary syndrome and type 2 diabetes mellitus.

De Leo V, Musacchio MC, Morgante G, La Marca A, Petraglia F.

Minerva Ginecol. 2004 Feb;56(1):53-62. Review.

PMID:
14973410
20.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055. Epub 2014 Jan 2.

PMID:
24388959

Supplemental Content

Support Center